Promacta
Hello ssdavi,
Another promising therapy for some refractory severe AA patients may be Promacta or eltrombopag. A recent research study from the NIH showed some response in 44% of a group of refractory patients. More than 6 months of ATG and cyclosporine had to have passed before pts were eligible for the study. Here is a link to the abstract, http://www.ncbi.nlm.nih.gov/pubmed/22762314. Good Luck tytd
__________________
possible low to int-1 MDS with predominant thrombocytopenia, mild anemia, dx 7/08, in watch and wait mode
|